DCVax platform technologies should likely seek broader approvals, assuming they get approval for DCVax-L for Glioblastoma and given the initial unusual and farsighted trial structure for DCVax Direct, which implies this approach by its very nature... ——— Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
Market Data 
Markets 
AI
